Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.

Who May Be Eligible (Plain English)

Who May Qualify: - Individuals aged 18 years or older - Individuals aged 18 years or older - Able to read and write in Turkish - Diagnosed with inflammatory bowel disease (IBD) for at least 6 months - In clinical remission (Harvey-Bradshaw Index score \< 5 or Simple Clinical Colitis Activity Index score \< 3) - Able to use a smartphone - Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address - Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom) - Willing to participate in the study voluntarily Who Should NOT Join This Trial: - Diagnosed with any psychiatric or cognitive disorder - Having any condition that impairs communication - Pregnant women - Patients receiving infusion-based treatment - Having an advanced chronic disease Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Individuals aged 18 years or older * Individuals aged 18 years or older * Able to read and write in Turkish * Diagnosed with inflammatory bowel disease (IBD) for at least 6 months * In clinical remission (Harvey-Bradshaw Index score \< 5 or Simple Clinical Colitis Activity Index score \< 3) * Able to use a smartphone * Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address * Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom) * Willing to participate in the study voluntarily Exclusion Criteria: * Diagnosed with any psychiatric or cognitive disorder * Having any condition that impairs communication * Pregnant women * Patients receiving infusion-based treatment * Having an advanced chronic disease

Treatments Being Tested

BEHAVIORAL

Nurse-led Telehealth Monitoring Program

Participants in the intervention group will be included in a structured telehealth monitoring program led by a nurse for 12 weeks.

OTHER

No intervention

Participants in the control group will only receive standard care. No additional interventions will be implemented during the 12-week period.

Locations (1)

Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology
Istanbul, Turkey (Türkiye)